IFF is expanding its pet portfolio with biotechnology solutions. The company’s expansion focuses on enzyme-driven palatability with sustainable and clean label ingredients for cost-effective production. IFF’s functional health technologies aim to support a complete pet life cycle. IFF is adding a range of enzyme-driven solutions to its pet portfolio, including Microsource CA and Betafin Pet.
